Clinical trial

Comparison of Awakening Versus Bedtime Dosing of Aspirin in Pre-Hypertension or…

NCT00449618 · University of Vigo, Other · Terminated

Key facts

NCT number NCT00449618
Title Comparison of Awakening Versus Bedtime Dosing of Aspirin in Pre-Hypertension or Mild Essential Hypertension
Official title A Prospective, Randomized, Multi-Center, Double-Blind Crossover Study to Compare Awakening Versus Bedtime Administration of 100 mg Aspirin or Placebo in Subjects With High-Normal Blood Pressure or Mild Essential Hypertension
Lead sponsor University of Vigo, Other
Collaborators Hospital Clinico Universitario de Santiago Bayer Industry
Status Terminated
Phase Phase 4
Study type Interventional
Conditions High-Normal Blood Pressure, Mild Essential Hypertension
Intervention type Device, Drug, Procedure
Interventions Aspirin 100 mg, Ambulatory blood pressure monitoring, Chronotherapy, timing of medication, Placebo
Enrollment 23
Start date Jan 1, 2007
Primary completion Dec 1, 2008
Completion Dec 1, 2008
First posted Mar 20, 2007
Last update posted Jan 5, 2009
Countries Spain

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies